본문 바로가기
KERD
논문KCI 등재

택사/저령 추출물이 사람 중간엽 줄기세포의 지방세포 분화에 미치는 영향

The Effect of Alisma canaliculatum and Polyporus umbellatus Extracts on Adipogenic Differentiation of Human Bone Marrow Derived Mesenchymal Stromal Stem cells

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: This study investigated the effect of purified medical herb extracts such as Alisma canaliculatum and Polyporus umbellatus on adipogenic differentiation of human bone marrow derived mesenchymal stromal stem cells (hBMSCs). Methods: Two different medical herb were extracted using hot distilled water. The optimal concentration of extracts were fixed at 100 ng/ml by means of cell viability and cytotoxic assay. To test the adipogenic differentiation ability of extracts, we induced the adipogenesis of hBMSCs for 21 days. At day 5, the cell was harvested to check mRNA and protein expression level of adipogenic related factors. The efficacy of lipid droplet formation was evaluated using the oil-red O staining method at days 21. Results: Two different medical herb extracts have no toxicity on hBMSCs. And two different medical herb extracts significantly decreased formation of lipid droplet compared with control groups in hBMSCs. The A. canaliculatum extract group showed the lowest mRNA and protein expression level of adipossgenic related transcription factors. This data suggests that extract of A. canaliculatum and P. umbellata decrease the adipogenic differentiation of hBMSCs. Conclusions: Our findings indicate that water-extract of A. canaliculatum and P. umbellata will be useful therapeutic reagents for prevention of obesity related disease such as diabetes, hyperlipidemia, coronary artery disease, and osteoporosis.

Abstract

Objective: This study investigated the effect of purified medical herb extracts such as Alisma canaliculatum and Polyporus umbellatus on adipogenic differentiation of human bone marrow derived mesenchymal stromal stem cells (hBMSCs). Methods: Two different medical herb were extracted using hot distilled water. The optimal concentration of extracts were fixed at 100 ng/ml by means of cell viability and cytotoxic assay. To test the adipogenic differentiation ability of extracts, we induced the adipogenesis of hBMSCs for 21 days. At day 5, the cell was harvested to check mRNA and protein expression level of adipogenic related factors. The efficacy of lipid droplet formation was evaluated using the oil-red O staining method at days 21. Results: Two different medical herb extracts have no toxicity on hBMSCs. And two different medical herb extracts significantly decreased formation of lipid droplet compared with control groups in hBMSCs. The A. canaliculatum extract group showed the lowest mRNA and protein expression level of adipossgenic related transcription factors. This data suggests that extract of A. canaliculatum and P. umbellata decrease the adipogenic differentiation of hBMSCs. Conclusions: Our findings indicate that water-extract of A. canaliculatum and P. umbellata will be useful therapeutic reagents for prevention of obesity related disease such as diabetes, hyperlipidemia, coronary artery disease, and osteoporosis.

참고문헌 (40)

  1. Martin DR, "Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow", Exp Hematol, 30(8), pp.879~886 (2001)
  2. Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284(5411), pp.143~147 (1999)
  3. Jung HS, "Peroxisome proliferator-activated receptor gamma", singal transducers and activators of transcription 5a pathway plays a key factor in adipogenesis of human bone marrow-derived stromal cells and 3T3-L1 preadipocytes, 2012, pp.21(3), 465~475
  4. Duque G, "Bone and fat connection in aging bone", Curr Opin Rheumatol, 20(4), pp.429~434 (2008)
  5. Moerman EJ, "Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma", stem cells : the role of PPAR-gamma2 transcription factor and TGF-beta, Aging Cell, pp.2004, 3(6)[DOI]
  6. Yeung DK, "Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation : a proton MR spectroscopy study", J Magn Reson Imaging, 22(2), pp.279~285 (2005)
  7. Ferrari S, "Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture", Arch Osteoporos, 11(1), pp.37~48 (2016)
  8. Magaziner J, "Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study", J Gerontol, 45, pp.M101~M107 (1990)
  9. Kawai M., "Fat targets for skeletal health", Nat Rev Rheumatol, 5(7), pp.365~372 (2009)
  10. Pei L., "Fat's loss is bone's gain", J Clin Invest, 113(6), pp.805~806 (2004)
  11. World Health Organization (WHO), "Obesity and overweight in Media centre", ~ (2011)
  12. Pourali P, "Wound healing property of a gel prepared by the combination of Pseudomonas aeruginosa alginate and Alhagi maurorum aqueous extract in rats", Dermatol Ther, 2018, pp.e12779~ (2018)
  13. 유성률, "홍화 추출물이 생쥐 골수 유래 중간엽 줄기세포의 지방분화에 미치는 영향", 대한한방내과학회지, 38(1), pp.1~9 (2017), 대한한방내과학회
  14. 장혜옥, "Effects of Extracts from Safflower Seeds on Osteoblastic Differentiation and Interacellular Free Calcium Concentration in MC3T3-E1 Cells", The Korean Journal of Physiology & Pharmacology, 9(1), pp.55~62 (2005), 대한약리학회
  15. Diel I, "Adverse effects of bisphosphonates : current issues", J Support Oncol, 5(10), pp.475~482 (2007)
  16. McClung M, "Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday", Am J Med, 126(1), pp.13~20 (2013)
  17. Chung HJ, "Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts", J Nat Prod, 24(80), pp.434~442 (2017)
  18. Seo BI, "The easily understanding herbology", pp.185~186 (2012), Kyungsan: publishing department of Daegu Haany university
  19. 정향숙, "고지방식이로 유발된 비만에 대한 택사의 항비만 효과", 대한본초학회지, 28(3), pp.95~106 (2013), 대한본초학회
  20. Lu W, "Pletelet aggregation potentiators from cho-rei", Chem Pharm Bull, 33(11), pp.5083~5087 (1985)
  21. Sato K, "Difference in fruiting capability of stocks in Grifola Frondosa and its allied species", Trans Mycol Soc Japan, 25, pp.205~209 (1984)
  22. Miyazaki T, "Relationship between the chemical structure and antitumor activity of glucans prepared from Grifolla umbellata", Carbohydrate Research, 69(1), pp.165~170 (1979)
  23. Ueno Y, "An antitumor activity of the alkali-soluble polysaccharide(and its derivatives)obtained from the sclerotia of Grifora umbellata", Carbohydrate Research, 101(1), pp.160~167 (1982)
  24. Zhang Y, "Effect of Polyporus umbellatus polysaccahride on function of macrophages in the peritoneal cavities of mice with lesions", Cheih Ho Tsa Chih, 11(4), pp.225~226 (1991)
  25. May L, "Therapeutic investigation of Polyporusumbellatus polysaccahride on the children with pure immunity", J Traditional Chinese Medicine(China), 3, pp.168~169 (1990)
  26. Chang YF, "Effect of Polyporus umbellatus polysaccahrides on macrophages of liver damaged mice", Intergrated J Chinese and Western Medicine(China), 11, pp.225~226 (1991)
  27. Xiong LL, "Therapeutic effect of combined therapy of Salvia miltiorrhizae and Polyporus umbellatus polysaccharide in the treatment of chronic hepatitis B", Cheih Ho Tsa Chih, 13(9), pp.516~517 (1993)
  28. You JS, "Combined effects fo chulling(Polyporus umbellatus)extract and mitomycin C on experimental liver cancer", Am J Chin Med, 22(1), pp.19~28 (1994)
  29. Ishida H, "Studies of the active substances in herbs used for hair treatment II Isolation of hair regrowth substances acerosyringone and polyporusterone A and B from Polyporus umbellatus fries", Biol Pharm Bull, 22(1), pp.1189~1192 (1999)
  30. Ishida H, "Studies of active substances in herbs used for hair treatment IV. The structure of the hair growth substance, polypurusterone A from Polyporus umbellatus fries", Chemical & Pharmaceutical Bulletin, 47(11), pp.1626~1628 (1999)
  31. 박종배, "복합생약추출물이 고지방식이를 급여한 쥐의 비만 억제에 미치는 영향", 아시안뷰티화장품학술지, 9(1), pp.25~34 (2011), 한국피부과학연구원
  32. 권혜진, "Statistical Trends in Family Medicine Journals", Korean Journal of Family Medicine, 33(1), pp.9~16 (2012), 대한가정의학회
  33. Padwal RS, "Drug treatments for obesity: orlistat, sibutramine, and rimonabant", Lancet, 369(9555), pp.71~77 (2007)
  34. Al-Tahami BA, "Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects", J Nippon Med Sch, 84(3), pp.125~132 (2017)
  35. LaFleur J, "Clinical risk factors for fracture in postmenopausal osteoporotic women : A review of the recent literature", Ann Pharmacother, 42(3), pp.375~386 (2008)
  36. Cao JJ, "Effects of obesity on bone metabolism", J Orthop Surg Res, 6, pp.30~ (2011)
  37. Chen JS, "Antiresorptive therapies for osteoporosis : a clinical overview", Nat Rev Endocrinol, 8(2), pp.81~91 (2011)
  38. Stepan JJ, "Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis", Endocr Regul, 37(4), pp.225~238 (2003)
  39. Wu JN, "An illustrated Chinese materia medica", pp.59~ (2005), Oxford University Press
  40. Kaminage T, "Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O- tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin", Oncology, 53(5), pp.382~385 (1996)

관련 논문AI추천

이 간행물의 다른 논문 (18건)